Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,244,000 | -1,062,000 | -813,000 | -10,000 | 47,000 |
| Depreciation Amortization | 710,000 | 511,000 | 344,000 | 185,000 | 576,000 |
| Income taxes - deferred | -45,000 | 6,000 | 7,000 | 16,000 | -477,000 |
| Accounts receivable | 42,000 | 32,000 | 15,000 | 65,000 | -64,000 |
| Other Working Capital | 360,000 | 465,000 | 245,000 | 147,000 | -56,000 |
| Other Operating Activity | 822,000 | 776,000 | 577,000 | -154,000 | 68,000 |
| Operating Cash Flow | $645,000 | $728,000 | $375,000 | $249,000 | $94,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -117,000 | -337,000 | -286,000 | -125,000 | -301,000 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -6,078,000 |
| Other Investing Activity | 24,000 | 24,000 | 15,000 | 8,000 | 11,000 |
| Investing Cash Flow | $-93,000 | $-313,000 | $-271,000 | $-117,000 | $-6,368,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,014,000 | 2,277,000 | 2,278,000 | 198,000 | 66,000 |
| Debt Repayment | -589,000 | -21,000 | -20,000 | -5,000 | -31,000 |
| Common Stock Issued | 359,000 | 359,000 | 362,000 | N/A | -6,000 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -250,000 |
| Dividend Paid | -22,000 | -16,000 | -11,000 | -5,000 | -23,000 |
| Other Financing Activity | -20,000 | -15,000 | -11,000 | -6,000 | -21,000 |
| Financing Cash Flow | $2,742,000 | $2,584,000 | $2,598,000 | $182,000 | $-265,000 |
| Beginning Cash Position | 544,000 | 544,000 | 544,000 | 544,000 | 7,083,000 |
| End Cash Position | 3,838,000 | 3,543,000 | 3,246,000 | 858,000 | 544,000 |
| Net Cash Flow | $3,294,000 | $2,999,000 | $2,702,000 | $314,000 | $-6,539,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 645,000 | 728,000 | 375,000 | 249,000 | 94,000 |
| Capital Expenditure | -293,000 | -337,000 | -286,000 | -125,000 | -301,000 |
| Free Cash Flow | 352,000 | 391,000 | 89,000 | 124,000 | -207,000 |